Abbott’s Eterna Spinal Cord Stimulation System Receives the US FDA’s Approval for the Treatment of Chronic Pain
- The US FDA has approved the Eterna SCS system, the smallest implantable, rechargeable spinal cord stimulator for chronic pain. The system uses BurstDR stimulation (SCS waveform technology) that mimics the natural firing patterns for superior pain relief
- The SCS technology showed a 23% more pain reduction over traditional waveform technology. The system can be wirelessly charged less than five times a year under normal use i.e., lowest recharge burden over other rechargeable SCS systems
- The device uses TotalScan MRI technology that allows for full-body MRI scans. The company offers iPhone integration for Eterna & its patient-focused mobile app displays real-time battery life & charging updates of the Eterna SCS system on a personal or Abbott-provided Apple device
Ref: Abbott | Image: Abbott
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at firstname.lastname@example.org.